WO2023021050 - VARIANTS OF ANKYRIN REPEAT DOMAINS
National phase entry:
Publication Number
WO/2023/021050
Publication Date
23.02.2023
International Application No.
PCT/EP2022/072884
International Filing Date
16.08.2022
Title **
[English]
VARIANTS OF ANKYRIN REPEAT DOMAINS
[French]
VARIANTS DE DOMAINES DE RÉPÉTITION D'ANKYRINE
Applicants **
ATHEBIO AG
Inventors
FORRER, Patrik
EAPEN, Rohan Sakariah
Priority Data
PCT/EP2021/072819
17.08.2021
EP
21199643.4
28.09.2021
EP
22151475.5
13.01.2022
EP
PCT/EP2022/060178
15.04.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2488 | |
| EPO | Filing, Examination, Granting | 9552 | |
| Japan | Filing, Examination, Granting | 2108 | |
| South Korea | Filing, Examination, Granting | 2032 | |
| USA | Filing, Examination, Granting | 7140 |
Total:
23,320
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Described herein are proteins comprising an ankyrin repeat domain with a mutation in the internal ankyrin repeat that is adjacent to the N-terminal capping module, in particular a mutation at position 23 of said internal ankyrin repeat, as well as related products and methods.[French]
L'invention concerne des protéines comprenant un domaine de répétition d'ankyrine avec une mutation dans la répétition d'ankyrine interne qui est adjacente au module de coiffage N-terminal, en particulier une mutation en position 23 de ladite séquence d'ankyrine interne, ainsi que des produits et des procédés associés.